CanSino Biologics Inc. (CASBF) Financial Statements
$2.60OTC: CASBFMarket Cap $908.20M
CanSino Biologics Inc. most recently reported annual revenue of $1.0B, net profit of $27.0M, revenue has compounded at 110.4% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.